Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Di Maio

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
ESMO Open|December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]L Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2022
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineM Di Maio, E Basch, F Denis, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.
Critical Reviews in Oncology/Hematology|June 12, 2016
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendationsS Novello, C Pinto, V Torri, et al.
British Journal of Cancer|January 20, 2011
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancerF De Vita, M Orditura, E Martinelli, et al.
ESMO Open|May 21, 2022
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific SocietiesA Russo, L Incorvaia, E Capoluongo, et al.
ESMO Open|August 20, 2021
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino studyA Raimondi, G Fucà, A G Leone, et al.
Gynecologic Oncology|April 26, 2021
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literatureG Giannone, G Scotto, D Katsaros, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
ESMO Open|December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]L Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2022
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineM Di Maio, E Basch, F Denis, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.
Critical Reviews in Oncology/Hematology|June 12, 2016
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendationsS Novello, C Pinto, V Torri, et al.
British Journal of Cancer|January 20, 2011
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancerF De Vita, M Orditura, E Martinelli, et al.
ESMO Open|May 21, 2022
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific SocietiesA Russo, L Incorvaia, E Capoluongo, et al.
ESMO Open|August 20, 2021
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino studyA Raimondi, G Fucà, A G Leone, et al.
Gynecologic Oncology|April 26, 2021
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literatureG Giannone, G Scotto, D Katsaros, et al.
Pageof 9